Capture & bid funnel
agents #32 · #33real + syntheticlive · 30sAgent #32 scans ClinicalTrials.gov for newly-posted, industry-sponsored trials (real leads, tagged with their NCT id) and adds a synthetic portfolio-derived feed for breadth (tagged ← STUDY). It scores fit, asks the model to qualify each lead (pursue / watch / pass), and drafts human-reviewable outreach for the pursue leads (✉ draft). It maintains the pipeline across scheduled scans — new leads accumulate, duplicates are skipped. Outreach is never sent automatically; advancing the funnel (#33) is human-gated; pricing is human-set; the award is an exec sign-off; promotion to live needs a Part 11 signature.
Sourcing agent health — #32
Stale · last sourced 86d agoPipeline
63
Real leads
9
AI-qualified
15
Last 7 days
0
- Scheduler paused — set CRONS_PAUSED=false in the Vercel project so the daily sourcing cron runs.
Real leads are public, read-only ClinicalTrials.gov registrations (no PHI, no scraping beyond the API). No sponsor is contacted and no outreach is sent — drafts are staged for a human to review and send (ADR 0013).
Daily scheduleloading…
Sourced
63- OPP-FE31fit 85Metabolic · Phase 1 · $20–50MpasssyntheticAI
- OPP-F406fit 90Metabolic · Phase 2 · <$5MpasssyntheticAI
- OPP-D401fit 90Metabolic · Phase 3 · <$5MpasssyntheticAI
- OPP-AECFfit 90Rare Disease · Phase 2 · <$5MpasssyntheticAI
- OPP-A9ECfit 90Metabolic · Phase 2 · <$5MpasssyntheticAI
- OPP-F133fit 97Rare Disease · Phase 2 · $5–20MwatchsyntheticAI
- OPP-0501fit 100Metabolic · Phase 4 · $50M+pursuesynthetic✉ draftAI
- NCT07654829fit 100Immunology · Phase 4 · $20–50M
- NCT07654751fit 100Immunology · Phase 4 · $20–50M
- NCT07654361fit 100Metabolic · Phase 3 · $50M+
- NCT07654283fit 100Immunology · Phase 2 · $20–50M
- NCT07654140fit 100Cardiology · Phase 2 · $20–50M
- NCT07654114fit 100Immunology · Phase 2 · $20–50M
- NCT07653685fit 100Oncology · Phase 2 · $20–50M
- NCT07652658fit 100Immunology · Phase 2 · $20–50M
- OPP-DEA4fit 70Rare Disease · Phase 3 · $20–50Msynthetic
- OPP-3A81fit 70Oncology · Phase 1 · <$5Msynthetic
- OPP-2DBAfit 70Oncology · Phase 4 · <$5Msynthetic
- OPP-55DAfit 75Rare Disease · Phase 3 · $50M+synthetic
- OPP-FBFCfit 77Oncology · Phase 1 · $5–20Msynthetic
- OPP-A0A0fit 77Immunology · Phase 1 · $5–20Msynthetic
- OPP-6388fit 77Oncology · Phase 1 · $5–20Msynthetic
- OPP-F7EDfit 85Immunology · Phase 4 · $20–50Msynthetic
- OPP-31BFfit 85Immunology · Phase 4 · $20–50Msynthetic
- OPP-D64Ffit 90Immunology · Phase 3 · <$5Msynthetic
- OPP-90A7fit 90Oncology · Phase 1 · $50M+synthetic
- OPP-7495fit 90Cardiology · Phase 3 · <$5Msynthetic
- OPP-C489fit 97Immunology · Phase 3 · $5–20Msynthetic
- OPP-D4BBfit 100Cardiology · Phase 2 · $50M+synthetic
- OPP-7C27fit 100Immunology · Phase 2 · $50M+synthetic
- OPP-VAX-014-ADJfit 97Immunology · Phase 2 · $5–20Mpursuesynthetic← VAX-014
- OPP-ONC-002-FUfit 97Oncology · Phase 3 · $5–20Mpursuesynthetic← ONC-002
- OPP-ONC-002-ADJfit 97Oncology · Phase 2 · $5–20Mpursuesynthetic← ONC-002
- OPP-RARE-007-FUfit 100Rare Disease · Phase 4 · $20–50Mpursuesynthetic← RARE-007
- OPP-RARE-007-ADJfit 97Rare Disease · Phase 3 · $5–20Mpursuesynthetic← RARE-007
- OPP-DERM-003-FUfit 97Immunology · Phase 3 · $5–20Mpursuesynthetic← DERM-003
- OPP-DERM-003-ADJfit 97Immunology · Phase 2 · $5–20Mpursuesynthetic← DERM-003
- OPP-CV-118-FUfit 100Cardiology · Phase 4 · $50M+pursuesynthetic← CV-118
- OPP-CV-118-ADJfit 100Cardiology · Phase 3 · $20–50Mpursuesynthetic← CV-118
- OPP-VAX-014-FUfit 100Immunology · Phase 3 · $20–50Mpursuesynthetic← VAX-014
- OPP-OBS-PMR-001-FUfit 97Metabolic · Phase 4 · $5–20Mpursuesynthetic← OBS-PMR-001
- OPP-OBS-PMR-001-ADJfit 97Metabolic · Phase 4 · $5–20Mpursuesynthetic← OBS-PMR-001
- OPP-DEA4fit 70Rare Disease · Phase 3 · $20–50Msynthetic
- OPP-3A81fit 70Oncology · Phase 1 · <$5Msynthetic
- OPP-2DBAfit 70Oncology · Phase 4 · <$5Msynthetic
- OPP-55DAfit 75Rare Disease · Phase 3 · $50M+synthetic
- OPP-FBFCfit 77Oncology · Phase 1 · $5–20Msynthetic
- OPP-A0A0fit 77Immunology · Phase 1 · $5–20Msynthetic
- OPP-6388fit 77Oncology · Phase 1 · $5–20Msynthetic
- OPP-F7EDfit 85Immunology · Phase 4 · $20–50Msynthetic
- OPP-31BFfit 85Immunology · Phase 4 · $20–50Msynthetic
- OPP-D64Ffit 90Immunology · Phase 3 · <$5Msynthetic
- OPP-90A7fit 90Oncology · Phase 1 · $50M+synthetic
- OPP-7495fit 90Cardiology · Phase 3 · <$5Msynthetic
- OPP-C489fit 97Immunology · Phase 3 · $5–20Msynthetic
- OPP-D4BBfit 100Cardiology · Phase 2 · $50M+synthetic
- OPP-7C27fit 100Immunology · Phase 2 · $50M+synthetic
- OPP-3F2Afit 90Oncology · Phase 3 · $50M+synthetic
- OPP-0A93fit 75Cardiology · Phase 2 · $20–50Msynthetic
- OPP-22D0fit 88Oncology · Phase 2 · $50M+synthetic
- OPP-91C4fit 82Cardiology · Phase 3 · $20–50Msynthetic
- OPP-7B11fit 85Immunology · Phase 2 · $20–50Msynthetic
- OPP-58EEfit 70Immunology · Phase 3 · $5–20Msynthetic
Qualified
0- —
Bid
0- —
Proposal
0- —
Bid defense
0- —
Awarded
0- —
Declined
0- —
Opportunities are staged records — review and sign them in staging.